loadpatents
name:-0.075453996658325
name:-0.099776983261108
name:-0.0092718601226807
Burnett; Duane A. Patent Filings

Burnett; Duane A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burnett; Duane A..The latest application filed is for "progranulin modulators and methods of using the same".

Company Profile
7.70.70
  • Burnett; Duane A. - Cambridge MA
  • Burnett; Duane A. - Wayland MA
  • Burnett; Duane A. - Bernardsville NJ US
  • - Bernardsville NJ US
  • Burnett; Duane A - Bernardsville NJ
  • Burnett; Duane A. - Fanwood NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Progranulin Modulators And Methods Of Using The Same
App 20220251084 - Burnett; Duane A. ;   et al.
2022-08-11
Progranulin Modulators And Methods Of Using The Same
App 20210163471 - Koenig; Gerhard ;   et al.
2021-06-03
Compounds, Compositions And Methods Of Use
App 20200270211 - Burnett; Duane A. ;   et al.
2020-08-27
Geminal substituted aminobenzisoxazole compounds as agonists of .alpha.7-nicotinic acetylcholine receptors
Grant 10,428,062 - Acharya , et al. October 1, 2
2019-10-01
Aminobenzisoxazole compounds as agonists of .alpha.7-nicotinic acetylcholine receptors
Grant 10,370,370 - Acharya , et al.
2019-08-06
Geminal substituted quinuclidine amide compounds as agonists of .alpha.-7 nicotonic acetylcholine receptors
Grant 10,183,938 - Acharya , et al. Ja
2019-01-22
Compounds, Compositions And Methods Of Use Against Stress Granules
App 20180305334 - Larsen; Glenn R. ;   et al.
2018-10-25
Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20180134696 - Acharya; Raksha ;   et al.
2018-05-17
Geminal Substituted Quinuclidine Amide Compounds As Agonists Of Alpha-7 Nicotonic Acetylcholine Receptors
App 20170369486 - ACHARYA; Raksha ;   et al.
2017-12-28
Oxadiazine compounds and methods of use thereof
Grant 9,802,927 - Acharya , et al. October 31, 2
2017-10-31
Fused morpholinopyrimidines and methods of use thereof
Grant 9,771,378 - Burnett , et al. September 26, 2
2017-09-26
Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20170247393 - Acharya; Raksha ;   et al.
2017-08-31
Oxadiazine Compounds And Methods Of Use Thereof
App 20170066753 - Acharya; Raksha ;   et al.
2017-03-09
Oxadiazine Compounds And Methods Of Use Thereof
App 20170050980 - Burnett; Duane A. ;   et al.
2017-02-23
Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20170044155 - Acharya; Raksha ;   et al.
2017-02-16
Fused Morpholinopyrimidines And Methods Of Use Thereof
App 20170044182 - Burnett; Duane A. ;   et al.
2017-02-16
5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
Grant 9,499,502 - Wu , et al. November 22, 2
2016-11-22
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
Grant 9,453,034 - Gilbert , et al. September 27, 2
2016-09-27
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use
Grant 9,365,589 - Cumming , et al. June 14, 2
2016-06-14
C2-azaspiro Iminothiazine Dioxides As Bace Inhibitors, Compositions, And Their Use
App 20160016975 - Gilbert; Eric J. ;   et al.
2016-01-21
Gamma secretase inhibitors
Grant 9,226,927 - Wu , et al. January 5, 2
2016-01-05
C2,c6 Oxacyclic-fused Thiazine Dioxide Compounds As Bace Inhibitors, Compositions, And Their Use
App 20150344500 - Cumming; Jared N. ;   et al.
2015-12-03
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
Grant 9,181,236 - Wu , et al. November 10, 2
2015-11-10
HCV NS3 protease inhibitors
Grant 8,987,195 - Bara , et al. March 24, 2
2015-03-24
Gamma secretase inhibitors
Grant 8,933,116 - Wu , et al. January 13, 2
2015-01-13
Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
Grant 8,907,086 - Bennett , et al. December 9, 2
2014-12-09
Gamma secretase modulators
Grant 8,809,318 - Zhu , et al. August 19, 2
2014-08-19
Gamma Secretase Inhibitors
App 20140227302 - Wu; Wen-Lian ;   et al.
2014-08-14
2-spiro-substituted Iminothiazines And Their Mono-and Dioxides As Bace Inhibitors, Compositions And Their Use
App 20140200213 - Wu; Wen-Lian ;   et al.
2014-07-17
5-substituted Iminothiazines And Their Mono- And Dioxides As Bace Inhibitors, Compositions, And Their Use
App 20140128382 - Wu; Wen-Lian ;   et al.
2014-05-08
Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
Grant 8,691,832 - Burnett , et al. April 8, 2
2014-04-08
Tetrahydropyranochromene gamma secretase inhibitors
Grant 8,664,411 - Wu , et al. March 4, 2
2014-03-04
Gamma Secretase Inhibitors
App 20140018342 - Wu; Wen-Lian ;   et al.
2014-01-16
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
Grant 08618123 -
2013-12-31
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
Grant 8,618,123 - Sasikumar , et al. December 31, 2
2013-12-31
Fused Bicyclic Heterocycles Useful As Dipeptidyl Peptidase-iv Inhibitors
App 20130324562 - Bennett; Chad E. ;   et al.
2013-12-05
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
Grant 8,569,521 - Asberom , et al. October 29, 2
2013-10-29
Tricyclic Heterocycles Useful As Dipeptidyl Peptidase-iv Inhibitors
App 20130261140 - Burnett; Duane A. ;   et al.
2013-10-03
Benzenesulfonyl-chromane, Thiochromane, Tetrahydronaphthalene And Related Gamma Secretase Inhibitors
App 20120264736 - Asberom; Theodros ;   et al.
2012-10-18
Gamma Secretase Modulators
App 20120129846 - Zhu; Zhaoning ;   et al.
2012-05-24
Gamma Secretase Modulators
App 20110306593 - Zhu; Zhaoning ;   et al.
2011-12-15
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
Grant 8,067,621 - Asberom , et al. November 29, 2
2011-11-29
Tetrahydropyranochromene Gamma Secretase Inhibitors
App 20110236400 - Wu; Wen-Lian ;   et al.
2011-09-29
mGluR1 antagonists as therapeutic agents
Grant 7,989,464 - Matasi , et al. August 2, 2
2011-08-02
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant RE42,461 - Rosenblum , et al. June 14, 2
2011-06-14
Benzenesulfonyl-chromane, Thiochromane, Tetrahydronaphthalene And Related Gamma Secretase Inhibitors
App 20110110948 - Sasikumar; Thavalakulamgara K. ;   et al.
2011-05-12
Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
Grant 7,902,157 - Burnett , et al. March 8, 2
2011-03-08
Azetidinone derivatives and methods of use thereof
Grant 7,884,080 - Aslanian , et al. February 8, 2
2011-02-08
Gamma Secretase Modulators
App 20110009392 - Zhu; Zhaoning ;   et al.
2011-01-13
Gamma Secretase Modulators
App 20100298381 - Zhu; Zhaoning ;   et al.
2010-11-25
Fused tricyclic mGluR1 antagonists as therapeutic agents
Grant 7,767,815 - Bennett , et al. August 3, 2
2010-08-03
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,741,289 - Burnett , et al. June 22, 2
2010-06-22
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,732,413 - Burnett , et al. June 8, 2
2010-06-08
Use of azetidinone compounds
Grant 7,723,020 - Altmann , et al. May 25, 2
2010-05-25
Pyridothienopyridazinone derivatives as mGluR1 antagonists
Grant 7,687,501 - Bennett , et al. March 30, 2
2010-03-30
mGluR1 antagonists as therapeutic agents
Grant 7,598,259 - Matasi , et al. October 6, 2
2009-10-06
mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS
App 20090192178 - Matasi; Julius J. ;   et al.
2009-07-30
Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents
App 20090137575 - Burnett; Duane A. ;   et al.
2009-05-28
2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
Grant 7,511,146 - Burnett , et al. March 31, 2
2009-03-31
mGluR1 Antagonists as Therapeutic Agents
App 20090082336 - Matasi; Julius J. ;   et al.
2009-03-26
Selective D.sub.1/D.sub.5 receptor antagonists for the treatment of obesity and CNS disorders
Grant 7,504,391 - Burnett , et al. March 17, 2
2009-03-17
Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disorders
Grant 7,498,441 - Sasikumar , et al. March 3, 2
2009-03-03
mGluR1 antagonists as therapeutic agents
Grant 7,485,648 - Matasi , et al. February 3, 2
2009-02-03
Fused tetracyclic mGluR1 antagonists as therapeutic agents
Grant 7,482,360 - Burnett , et al. January 27, 2
2009-01-27
Fused Tetracyclic Mglur1 Antagonists As Therapeutic Agents
App 20080312218 - Burnett; Duane A. ;   et al.
2008-12-18
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,459,442 - Burnett , et al. December 2, 2
2008-12-02
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
App 20080234248 - Burnett; Duane A. ;   et al.
2008-09-25
Substituted n-aryl amidines as selective D.sub.1 dopamine receptor antagonists for the treatment of obesity and CNS disorders
Grant 7,423,149 - Burnett , et al. September 9, 2
2008-09-09
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
App 20080207585 - Burnett; Duane A. ;   et al.
2008-08-28
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20080200446 - Burnett; Duane A. ;   et al.
2008-08-21
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,378,518 - Burnett , et al. May 27, 2
2008-05-27
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,368,563 - Burnett , et al. May 6, 2
2008-05-06
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,368,562 - Burnett , et al. May 6, 2
2008-05-06
Azetidinone Derivatives and Methods of Use Thereof
App 20080076751 - Aslanian; Robert G. ;   et al.
2008-03-27
Azetidine And Azetidone Derivatives Useful In Treating Pain And Disorders Of Lipid Metabolism
App 20080070888 - McKittrick; Brian A. ;   et al.
2008-03-20
Azetidine And Azetidone Derivatives Useful In Treating Pain And Disorders Of Lipid Metabolism
App 20080070889 - BURNETT; DUANE A. ;   et al.
2008-03-20
Spirocyclic Azetidinone Compounds and Methods of Use Thereof
App 20080070890 - Burnett; Duane A. ;   et al.
2008-03-20
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
App 20070197581 - Asberom; Theodros ;   et al.
2007-08-23
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20070155676 - Burnett; Duane A. ;   et al.
2007-07-05
Substituted azetidinone compunds, processes for preparing the same, formulations and uses thereof
App 20070155675 - Burnett; Duane A. ;   et al.
2007-07-05
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20070155674 - Burnett; Duane A. ;   et al.
2007-07-05
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,235,543 - Burnett , et al. June 26, 2
2007-06-26
Use of azetidinone compounds
App 20070105141 - Altmann; Scott W. ;   et al.
2007-05-10
2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
Grant 7,214,691 - Wu , et al. May 8, 2
2007-05-08
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
Grant 7,211,574 - Wu , et al. May 1, 2
2007-05-01
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,208,486 - Burnett , et al. April 24, 2
2007-04-24
Fused tricyclic mGluR1 antagonists as therapeutic agents
App 20070072863 - Bennett; Chad E. ;   et al.
2007-03-29
Fused tricyclic mGIuR1 antagonists as therapeutic agents
App 20070072864 - Bennett; Chad E. ;   et al.
2007-03-29
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
Grant 7,192,944 - Burnett , et al. March 20, 2
2007-03-20
Use of azetidinone compounds
Grant 7,144,696 - Altmann , et al. December 5, 2
2006-12-05
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
Grant 7,109,207 - Burnett , et al. September 19, 2
2006-09-19
mGluR1 Antagonists as therapeutic agents
App 20060167029 - Matasi; Julius J. ;   et al.
2006-07-27
Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
Grant 7,030,113 - Sasikumar , et al. April 18, 2
2006-04-18
mGluR1 antagonists as therapeutic agents
App 20060009477 - Matasi; Julius J. ;   et al.
2006-01-12
Use of azetidinone compounds
App 20050208568 - Altmann, Scott W. ;   et al.
2005-09-22
Use of azetidinone compounds
Grant 6,933,107 - Altmann , et al. August 23, 2
2005-08-23
Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders
App 20050137210 - Burnett, Duane A. ;   et al.
2005-06-23
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
Grant 6,903,123 - Burnett , et al. June 7, 2
2005-06-07
Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
App 20050085488 - Sasikumar, Thavalakulamgara K. ;   et al.
2005-04-21
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
App 20050075325 - Burnett, Duane A. ;   et al.
2005-04-07
2-Substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
App 20050054628 - Burnett, Duane A. ;   et al.
2005-03-10
2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
App 20050049269 - Wu, Wen-Lian ;   et al.
2005-03-03
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20040198700 - Burnett, Duane A. ;   et al.
2004-10-07
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20040180861 - Burnett, Duane A. ;   et al.
2004-09-16
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
App 20040180860 - Burnett, Duane A. ;   et al.
2004-09-16
Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disorders
App 20040176355 - Sasikumar, Thavalakulamgara K. ;   et al.
2004-09-09
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
App 20040157822 - Burnett, Duane A. ;   et al.
2004-08-12
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
App 20040058906 - Wu, Wen-Lian ;   et al.
2004-03-25
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
App 20040024002 - Burnett, Duane A. ;   et al.
2004-02-05
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
Grant 6,664,273 - Burnett , et al. December 16, 2
2003-12-16
Use of azetidinone compounds
App 20030215869 - Altmann, Scott W. ;   et al.
2003-11-20
Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
App 20030199549 - Burnett, Duane A. ;   et al.
2003-10-23
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
App 20030195185 - Burnett, Duane A. ;   et al.
2003-10-16
Use of azetidinone compounds
Grant 6,632,933 - Altmann , et al. October 14, 2
2003-10-14
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant RE37,721 - Rosenblum , et al. May 28, 2
2002-05-28
Use of azetidinone compounds
App 20020009714 - Altmann, Scott W. ;   et al.
2002-01-24
Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
Grant 5,846,966 - Rosenblum , et al. December 8, 1
1998-12-08
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,767,115 - Rosenblum , et al. June 16, 1
1998-06-16
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,744,467 - McKittrick , et al. April 28, 1
1998-04-28
Substituted .beta.-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
Grant 5,688,787 - Burnett , et al. November 18, 1
1997-11-18
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
Grant 5,656,624 - Vaccaro , et al. August 12, 1
1997-08-12
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,633,246 - McKittrick , et al. May 27, 1
1997-05-27
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,631,365 - Rosenblum , et al. May 20, 1
1997-05-20
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
Grant 5,624,920 - McKittrick , et al. April 29, 1
1997-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed